Theratechnologies Stock Price To Earning
TH Stock | CAD 1.77 0.02 1.12% |
Theratechnologies fundamentals help investors to digest information that contributes to Theratechnologies' financial success or failures. It also enables traders to predict the movement of Theratechnologies Stock. The fundamental analysis module provides a way to measure Theratechnologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Theratechnologies stock.
Theratechnologies | Price To Earning |
Theratechnologies Company Price To Earning Analysis
Theratechnologies' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Theratechnologies Price To Earning | (52.28) X |
Most of Theratechnologies' fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Theratechnologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Theratechnologies Price To Earning Driver Correlations
Understanding the fundamental principles of building solid financial models for Theratechnologies is extremely important. It helps to project a fair market value of Theratechnologies Stock properly, considering its historical fundamentals such as Price To Earning. Since Theratechnologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Theratechnologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Theratechnologies' interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition |
Theratechnologies Retained Earnings
Retained Earnings |
|
Based on the latest financial disclosure, Theratechnologies has a Price To Earning of -52.28 times. This is 302.32% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The price to earning for all Canada stocks is notably higher than that of the company.
Theratechnologies Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Theratechnologies' direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Theratechnologies could also be used in its relative valuation, which is a method of valuing Theratechnologies by comparing valuation metrics of similar companies.Theratechnologies is currently under evaluation in price to earning category among related companies.
Theratechnologies Current Valuation Drivers
We derive many important indicators used in calculating different scores of Theratechnologies from analyzing Theratechnologies' financial statements. These drivers represent accounts that assess Theratechnologies' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Theratechnologies' important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 713.9M | 1.2B | 830.7M | 41.9M | 37.7M | 35.8M | |
Enterprise Value | 756.5M | 1.2B | 873.5M | 66.8M | 60.1M | 57.1M |
Theratechnologies Fundamentals
Return On Equity | -11.17 | ||||
Return On Asset | -0.0455 | ||||
Profit Margin | (0.23) % | ||||
Operating Margin | (0.14) % | ||||
Current Valuation | 102.07 M | ||||
Shares Outstanding | 45.98 M | ||||
Shares Owned By Insiders | 6.28 % | ||||
Shares Owned By Institutions | 48.92 % | ||||
Number Of Shares Shorted | 14.88 K | ||||
Price To Earning | (52.28) X | ||||
Price To Book | 19.46 X | ||||
Price To Sales | 1.11 X | ||||
Revenue | 81.76 M | ||||
Gross Profit | 56.22 M | ||||
EBITDA | (2.94 M) | ||||
Net Income | (23.96 M) | ||||
Cash And Equivalents | 9.21 M | ||||
Cash Per Share | 0.35 X | ||||
Total Debt | 7.29 M | ||||
Debt To Equity | 6.46 % | ||||
Current Ratio | 1.90 X | ||||
Book Value Per Share | (0.54) X | ||||
Cash Flow From Operations | (5.68 M) | ||||
Short Ratio | 0.92 X | ||||
Earnings Per Share | (0.79) X | ||||
Price To Earnings To Growth | (199.00) X | ||||
Target Price | 6.42 | ||||
Number Of Employees | 103 | ||||
Beta | 1.81 | ||||
Market Capitalization | 81.38 M | ||||
Total Asset | 77.77 M | ||||
Retained Earnings | (408.66 M) | ||||
Working Capital | 16 M | ||||
Current Asset | 34.42 M | ||||
Current Liabilities | 16.85 M | ||||
Net Asset | 77.77 M |
About Theratechnologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Theratechnologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theratechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theratechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Theratechnologies Stock analysis
When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |